OUTLAST

Reagents for research purposes, drug discovery and development; Reagents for clinical cancer treatment research; biotechnology platform for developing and engineering therapeutic cells for drug research and development, consisting of therapeutic proteins and therapeutic antibodies for the treatment of cancer; biotechnology platform for developing and engineering therapeutic cells, consisting of CAR-T cells, therapeutic medical antibodies, therapeutic agents and cellular function activating agents for the treatment of cancer

Biological preparations, namely, preparations for use in the treatment of cancer; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, namely, T-Cell therapy; cells for medical or clinical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer; medical diagnostic reagents for the treatment of cancer; therapeutic preparations in the nature of an engineered cell therapy platform consisting of CAR-T cells for the treatment of cancer; biotechnology platform for the treatment of cancer through developing and engineering therapeutic cells, consisting of CAR-T cells, therapeutic medical antibodies, therapeutic agents and cellular function activating agents; clinical medical reagents for the treatment of cancer